| __timestamp | AbbVie Inc. | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 3297000000 | 14182353 |
| Thursday, January 1, 2015 | 4285000000 | 15503028 |
| Friday, January 1, 2016 | 4366000000 | 16183585 |
| Sunday, January 1, 2017 | 4982000000 | 22382849 |
| Monday, January 1, 2018 | 10329000000 | 33038206 |
| Tuesday, January 1, 2019 | 6407000000 | 31777040 |
| Wednesday, January 1, 2020 | 6557000000 | 41464134 |
| Friday, January 1, 2021 | 7084000000 | 67178053 |
| Saturday, January 1, 2022 | 6510000000 | 52531000 |
| Sunday, January 1, 2023 | 8453000000 | 68914000 |
| Monday, January 1, 2024 | 12791000000 |
In pursuit of knowledge
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, AbbVie Inc. has consistently outpaced Pharming Group N.V. in R&D investments. From 2014 to 2023, AbbVie's R&D expenses surged by approximately 156%, peaking in 2018 with a remarkable 10 billion dollars. In contrast, Pharming Group N.V. demonstrated a steady yet modest growth of around 386% in the same period, reaching its highest R&D expenditure in 2023. This disparity highlights AbbVie's strategic focus on maintaining a robust pipeline of new therapies, while Pharming Group N.V. is gradually increasing its investment to enhance its competitive edge. As the pharmaceutical industry continues to evolve, these R&D trends underscore the importance of sustained investment in innovation to drive future growth and success.
Research and Development: Comparing Key Metrics for AbbVie Inc. and AstraZeneca PLC
Comparing Innovation Spending: AbbVie Inc. and Arrowhead Pharmaceuticals, Inc.
Research and Development Investment: AbbVie Inc. vs BioCryst Pharmaceuticals, Inc.
R&D Spending Showdown: AstraZeneca PLC vs Pharming Group N.V.
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Pharming Group N.V.
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Pharming Group N.V.
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Pharming Group N.V.
Comparing Innovation Spending: Biogen Inc. and Pharming Group N.V.
Who Prioritizes Innovation? R&D Spending Compared for Pharming Group N.V. and ACADIA Pharmaceuticals Inc.
Pharming Group N.V. vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Pharming Group N.V. and Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Pharming Group N.V. and BioCryst Pharmaceuticals, Inc.